KOD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
KOD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Kodiak Sciences's EBITDA per Share for the three months ended in Sep. 2024 was $-0.71. Its EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-3.14.
During the past 3 years, the average EBITDA per Share Growth Rate was -16.70% per year. During the past 5 years, the average EBITDA per Share Growth Rate was -27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.
The historical rank and industry rank for Kodiak Sciences's EBITDA per Share or its related term are showing as below:
During the past 8 years, the highest 3-Year average EBITDA per Share Growth Rate of Kodiak Sciences was -16.70% per year. The lowest was -71.40% per year. And the median was -28.20% per year.
Kodiak Sciences's EBITDA for the three months ended in Sep. 2024 was $-37.25 Mil.
During the past 3 years, the average EBITDA Growth Rate was -22.10% per year. During the past 5 years, the average EBITDA Growth Rate was -57.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.
During the past 8 years, the highest 3-Year average EBITDA Growth Rate of Kodiak Sciences was -22.10% per year. The lowest was -93.90% per year. And the median was -70.10% per year.
The historical data trend for Kodiak Sciences's EBITDA per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kodiak Sciences Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EBITDA per Share | Get a 7-Day Free Trial | -1.23 | -2.82 | -4.99 | -6.18 | -4.48 |
Kodiak Sciences Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
EBITDA per Share | Get a 7-Day Free Trial | -0.82 | -1.01 | -0.69 | -0.73 | -0.71 |
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Kodiak Sciences's EBITDA per Share for the fiscal year that ended in Dec. 2023 is calculated as
EBITDA per Share | (A: Dec. 2023 ) | ||
= | EBITDA | / | Shares Outstanding (Diluted Average) | = | -234.531 | / | 52.414 |
= | -4.47 |
Kodiak Sciences's EBITDA per Share for the quarter that ended in Sep. 2024 is calculated as
EBITDA per Share | (Q: Sep. 2024 ) | ||
= | EBITDA | / | Shares Outstanding (Diluted Average) | = | -37.249 | / | 52.616 |
= | -0.71 |
EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kodiak Sciences (NAS:KOD) EBITDA per Share Explanation
EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.
While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.
The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.
EBITDA can be thought of as the cash a business generates that is available to:
Add more inventoryEBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.
A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.
Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.
Be Aware
Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.
EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.
Thank you for viewing the detailed overview of Kodiak Sciences's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
John A. Borgeson | officer: See Remarks | 1200 PAGE MILL ROAD, PALO ALTO CA 94304 |
Jason Ehrlich | officer: See Remarks | 1200 PAGE MILL ROAD, PALO ALTO CA 94304 |
Baker Bros. Advisors Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Victor Perlroth | director, 10 percent owner, officer: Chairman, President and CEO | 1200 PAGE MILL ROAD, PALO ALTO CA 94304 |
Julian Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Felix Baker | director, 10 percent owner | BAKER BROS. ADVISORS LP, 860 WASHINGTON STREET 3RD FLOOR, NEW YORK NY 10014 |
Baker Brothers Life Sciences Lp | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
L.p. 667, | director, 10 percent owner | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Charles A Bancroft | director | BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCE LINE ROAD, PRINCETON NJ 08543 |
Hong Liang | officer: See Remarks | 2631 HANOVER STREET, PALO ALTO CA 94304 |
Richard S Levy | director | 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK NY 10014 |
Taiyin Yang | director | 2631 HANOVER STREET, PALO ALTO CA 94304 |
Robert Profusek | director | P.O. BOX 696000, SAN ANTONIO TX 78269-6000 |
Bassil I Dahiyat | director | C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
From GuruFocus
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By PRNewswire • 05-14-2024
By GuruFocus Research • 02-07-2024
By PRNewswire • 11-11-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By PRNewswire • 05-15-2024
By GuruFocus Research • 02-07-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.